Based on histological pattern, SMARCB1-deficient carcinoma has been previously likely included in the historical spectrum of SNUC, basaloid nonkeratinizing SCC or myoepithelial carcinoma. This evidence concerns the gene SMARCB1 and malignant myoepithelioma.